Decheng Capital Global Life Sciences Fund IV, L.P. - Dec 31, 2024 SCHEDULE 13G Report for Upstream Bio, Inc. Common Stock, par value $0.001 per share (UPB)

Filing Manager
Decheng Capital Global Life Sciences Fund IV, L.P.
Reporting Manager
Xiangmin Cui
Security
Upstream Bio, Inc. Common Stock, par value $0.001 per share
Symbol
UPB
Shares outstanding
53.9M shares
Disclosed Ownership
3.29M shares
Ownership
6.1%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 05:38 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Decheng Capital Global Life Sciences Fund IV, L.P. 5.8% 3.09M 0 3.09M /s/ Xiangmin Cui By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Decheng Capital Management IV (Cayman), LLC 5.8% 3.09M 0 3.09M /s/ Xiangmin Cui By Xiangmin Cui, Manager
Decheng Capital Global Healthcare Fund (Master), LP 0.4% 200K 0 200K /s/ Xiangmin Cui By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Decheng Capital Global Healthcare GP, LLC 0.4% 200K 0 200K /s/ Xiangmin Cui By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Xiangmin Cui 6.1% 3.29M 0 3.29M /s/ Xiangmin Cui Xiangmin Cui